Intravenous diltiazem for the treatment of patients with atrial fibrillation or flutter and moderate to severe congestive heart failure

This publication has 26 references indexed in Scilit:

• Effects of intravenous diltiazem on rapid atrial fibrillation accompanied by congestive heart failure
  The American Journal of Cardiology, 1991
• Intravenous Diltiazem in Patients with Atrial Fibrillation/Atrial Flutter
  Clinical Drug Investigation, 1991
• Negative Inotropic Properties of Isradipine, Nifedipine, Diltiazem, and Verapamil in Diseased Human Myocardial Tissue
  Journal of Cardiovascular Pharmacology, 1990
• Different cardiodepressant potency of various calcium antagonists in human myocardium
  The American Journal of Cardiology, 1990
• Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter
  The American Journal of Cardiology, 1989
• Hemodynamic effects of intravenous diltiazem with impaired left ventricular function
  The American Journal of Cardiology, 1984
• Comparative effects of verapamil, diltiazem, and nifedipine on hemodynamics and left ventricular function during acute myocardial ischemia in dogs.
  Circulation, 1984
• Differential effects of systemic and intracoronary calcium channel blocking agents on global and regional left ventricular function in conscious dogs
  American Heart Journal, 1981
• Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart disease
  The American Journal of Cardiology, 1981
• Verapamil for Control of Ventricular Rate in Paroxysmal Supraventricular Tachycardia and Atrial Fibrillation or Flutter
  Annals of Internal Medicine, 1981